NCT00527124 2018-08-09Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyNational Cancer Institute (NCI)Phase 2 Terminated57 enrolled 12 charts